Cancer therapy biotech Heat Biologics files for a $20 million IPO

By Renaissance Capital,

Shutterstock photo

Heat Biologics, which is developing cellular therapeutic vaccines for cancer therapy, filed on Monday with the SEC to raise up to $20 million in an initial public offering.

The Chapel Hill, NC-based company, which was founded in 2008 and has been awarded $0.6 million in grants since inception, plans to list on the NASDAQ under the symbol HEAX. Heat Biologics initially filed confidentially on December 24, 2012. Aegis Capital is the sole bookrunner on the deal. No pricing terms were disclosed.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines IPOs
Referenced Stocks: HEAX

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by